Detalhe da pesquisa
1.
Adjuvant chemotherapy in patients with ER-negative/HER2-negative, T1abN0 breast cancer: a nationwide study.
Breast Cancer Res Treat
; 198(1): 103-112, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576678
2.
Benefit of adjuvant chemotherapy and trastuzumab in patients with HER2-positive, node-negative breast tumors ≤ 10 mm: a nationwide study.
Breast Cancer Res Treat
; 196(1): 197-206, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36076126
3.
Adjuvant treatment with trastuzumab of patients with HER2-positive, T1a-bN0M0 breast tumors: A systematic review and meta-analysis.
Crit Rev Oncol Hematol
; 184: 103952, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854373